Vivos Therapeutics and CFO Bradford Amman signed a separation agreement on July 31, 2026, resulting in his resignation from all executive and board roles while retaining an advisory position to support a transition.
Vivos Therapeutics and CFO Bradford Amman signed a separation agreement on July 31, 2026, resulting in his resignation from all executive and board roles while retaining an advisory position to support a transition.